Clinical Trials Browser

Phase 1/2 × Interventional × Pemphigoid, Benign Mucous Membrane × Clear all

NCT02126020 2017-04-07

Topical Infliximab in Autoimmune Eyes With Keratoprosthesis

Phase 1/2 Withdrawn

Pemphigoid, Benign Mucous Membrane, Stevens-Johnson Syndrome, Syndrome